Advance Biopharma Tech Transfer Using Process Modeling and Simulation

While biotherapeutics is one of the fastest growing sectors in life sciences today, the tech transfer process still takes many years. Regulatory approval can be time consuming—from conducting clinical trials to achieving a validated process design.

In this on-demand webinar, Dr. Monica Lomeli, Pharma Principal Solution Consultant at AspenTech, and Dr. Mark-John Bruwer, Senior Director of Strategic Product Marketing at AspenTech, discuss how regulators, such as the FDA, are implementing process modeling and simulation to accelerate knowledge creation for faster, more efficient system design. Learn how innovations including mechanistic and hybrid modeling enable you to:

  • Rapidly design for optimal yield, shorter cycle time and robust operation
  • Gain new insights into the optimization of downstream purification processes
  • Leverage the same science- and engineering-based approach used by regulators

Watch to learn how you can expand your toolset to advance tech transfer and accelerate regulatory submissions.

Advance Biopharma Tech Transfer Using Process Modeling and Simulation

Why we collect this data

AspenTech is collecting and may process your personal data for a variety of reasons related to our business and our ability to deliver the best possible products, customer support service and overall user experience. Accordingly, we may use your personal data to administer research surveys, to accurately deliver contracted services, to register you for events, to understand your preferences and to detect and prevent any fraudulent or unauthorized activities. Please refer to AspenTech’s Privacy and Security Policy, which is available here, for more information regarding our collection and processing of your personal data.

Advance Biopharma Tech Transfer Using Process Modeling and Simulation

Hello . If this is not you

Thank you for viewing this on-demand webinar

If you weren't redirected, click here